Chapman, Eloise

Publications

Sort by

Co-Author Network

selected publications

Attitudes and beliefs regarding complementary and alternative medicine in a diverse gynecologic oncology patient population. Gynecologic oncology reports. 2023 Academic Article GET IT
Achieving diversity in clinical trial enrollment by reducing burden and increasing value: A patient-centered approach. Gynecologic oncology. 2023 Editorial Article GET IT
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature. Gynecologic oncology. 2023 Review GET IT
Web-based tool for cancer family history collection: A prospective randomized controlled trial. Gynecologic oncology. 2023 Academic Article GET IT
Do people with hereditary cancer syndromes inform their at-risk relatives? A systematic review and meta-analysis. PEC innovation. 2023 Academic Article GET IT
Times cited: 1
Landmark Series on Disparities: Uterine Cancer and Strategies for Mitigation. Annals of surgical oncology. 2022 Review GET IT
Expanding Medicaid Improves Outcomes in Gynecologic Malignancies, But is it Enough?. Annals of surgical oncology. 2022 Editorial Article GET IT
What happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing. Cancer. 2022 Academic Article GET IT
Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?. Familial cancer. 2022 Academic Article GET IT
Times cited: 1
Understanding Perceived Barriers to Colposcopy Follow-Up Among Underserved Women at an Urban Teaching Hospital: A Qualitative Study. Journal of lower genital tract disease. 2022 Academic Article GET IT
Times cited: 1
Cascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Review GET IT
Times cited: 8
Genetic Testing for All: Overcoming Disparities in Ovarian Cancer Genetic Testing. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2022 Review GET IT
Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting. Gynecologic oncology reports. 2022 Academic Article GET IT
Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based review. Gynecologic oncology. 2022 Review GET IT
Times cited: 4
COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic. Gynecologic oncology. 2021 Academic Article GET IT
Times cited: 2
Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence. International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists. 2021 Academic Article GET IT
Times cited: 2
A Race-Conscious Analysis of the Use of Transvaginal Ultrasonography in the Evaluation of Postmenopausal Bleeding. JAMA oncology. 2021 Comment GET IT
Sex-Related Differences in Clinical Presentation and Risk Factors for Mortality in Patients Hospitalized With Coronavirus Disease 2019 in New York City. Open forum infectious diseases. 2021 Academic Article GET IT
Times cited: 4
Leveraging Health Information Technology to Collect Family Cancer History: A Systematic Review and Meta-Analysis. JCO clinical cancer informatics. 2021 Review GET IT
Times cited: 1
Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis. Gynecologic oncology. 2021 Review GET IT
Times cited: 18
Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database. American journal of clinical oncology. 2021 Academic Article GET IT
Times cited: 3
Financial toxicity, mental health, and gynecologic cancer treatment: The effect of the COVID-19 pandemic among low-income women in New York City. Cancer. 2021 Academic Article GET IT
Times cited: 17
Racial disparities in patients with coronavirus disease 2019 infection and gynecologic malignancy. Cancer. 2020 Academic Article GET IT
Times cited: 6
Adapting and avoiding coping strategies for women with ovarian cancer during the COVID-19 pandemic. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 17
Treatment patterns and outcomes among women with brain metastases from gynecologic malignancies. 2020 GET IT
Times cited: 5
Gynecologic oncology care during the COVID-19 pandemic at three affiliated New York City hospitals. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 26
Fertility sparing surgery for patients with FIGO stage I clear cell ovarian carcinoma: a database analysis and systematic review of the literature. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2020 Academic Article GET IT
Times cited: 10
Molecular Profiles of Mixed Endometrial Carcinoma. The American journal of surgical pathology. 2020 Academic Article GET IT
Times cited: 8
Racial and Ethnic Disparities in Genetic Testing at a Hereditary Breast and Ovarian Cancer Center. Journal of general internal medicine. 2020 Academic Article GET IT
Times cited: 55
Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer. American journal of obstetrics and gynecology. 2020 Academic Article GET IT
Times cited: 76
Clinicopathologic features of endometrial cancer with mismatch repair deficiency. Ecancermedicalscience. 2020 Academic Article GET IT
Times cited: 34
Is hysterectomy necessary for the treatment of preinvasive stratified mucin producing intraepithelial lesions of the cervix?. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2020 Academic Article GET IT
Times cited: 2
Promoting health equity in the era of COVID-19. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 16
Cervical carcinoma in the setting of uterovaginal prolapse: comparing standard versus tailored management. 2020 GET IT
Times cited: 4
Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2020 Academic Article GET IT
Times cited: 1
Multiple malignant transformations of an ovarian mature cystic teratoma. 2020 GET IT
Times cited: 11
Primary malignant ovarian carcinoid; management and outcomes. Gynecologic oncology. 2020 Academic Article GET IT
Times cited: 5
Prospective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 33
Disparities in the Use of Adjuvant External Beam Radiation Therapy in Node-positive Cervical Cancer Patients Following Hysterectomy. American journal of clinical oncology. 2020 Academic Article GET IT
Times cited: 2
Acute Myeloid Leukemia Presenting as Myeloid Sarcoma with a Predisposition to the Gynecologic Tract. 2019 GET IT
Times cited: 15
Bridging the Gap: A Priorities Assessment Tool to Support Shared Decision Making, Maximize Appointment Time, and Increase Patient Satisfaction in Women With Ovarian Cancer. JCO oncology practice. 2019 Academic Article GET IT
Times cited: 6
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma. JAMA oncology. 2019 Academic Article GET IT
Times cited: 273
Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma. Gynecologic oncology. 2019 Academic Article GET IT
Times cited: 4
Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population?. Cancer. 2019 Review GET IT
Times cited: 45
Evaluation of lysophosphatidic acid in vaginal fluid as a biomarker for ovarian cancer: A pilot study. European journal of obstetrics & gynecology and reproductive biology: X. 2019 Academic Article GET IT
Times cited: 10
Prognostic significance of residual disease in advanced stage malignant ovarian germ cell tumors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2019 Academic Article GET IT
Times cited: 5
Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center. Cancer. 2018 Academic Article GET IT
Times cited: 12
Role of adjuvant chemotherapy in the management of non-granulosa cell ovarian sex cord-stromal tumors. Journal of gynecologic oncology. 2018 Academic Article GET IT
Times cited: 7
Minimally Invasive Staging of Apparent Stage I Malignant Ovarian Germ Cell Tumors: Prevalence and Outcomes. Journal of minimally invasive gynecology. 2018 Academic Article GET IT
Times cited: 4
Small Cell Carcinoma of the Ovary: A Rare Tumor With a Poor Prognosis. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2018 Academic Article GET IT
Times cited: 18
Cauda equina syndrome secondary to leptomeningeal metastases from recurrent primary peritoneal carcinoma. 2018 GET IT
Times cited: 6
Safety of Fertility-Sparing Surgery for Premenopausal Women With Sex Cord-Stromal Tumors Confined to the Ovary. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 2017 Academic Article GET IT
Times cited: 17
Fertility-preserving surgery for advanced stage ovarian germ cell tumors. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 25
Management and prognosis of ovarian yolk sac tumors; an analysis of the National Cancer Data Base. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 26
Should epithelial ovarian carcinoma metastatic to the inguinal lymph nodes be assigned stage IVB?. Gynecologic oncology. 2017 Academic Article GET IT
Times cited: 17
Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?. Journal of gynecologic oncology. 2017 Academic Article GET IT
Times cited: 26
Safety of ovarian preservation in premenopausal women with stage I uterine sarcoma. Journal of gynecologic oncology. 2017 Academic Article GET IT
Times cited: 35
Rhabdomyosarcoma of the lower female genital tract: an analysis of 144 cases. Archives of gynecology and obstetrics. 2017 Academic Article GET IT
Times cited: 31
Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma. Gynecologic oncology. 2016 Academic Article GET IT
Times cited: 28
Feasibility and Learning Curve of Robotic Laparoendoscopic Single-Site Surgery in Gynecology. Journal of minimally invasive gynecology. 2016 Academic Article GET IT
Times cited: 25
Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecologic oncology. 2014 Review GET IT
Times cited: 127
Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy. Gynecologic oncology. 2012 Academic Article GET IT
Times cited: 70
Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia. The Journal of reproductive medicine. 2012 Academic Article GET IT
Times cited: 31
Use of multimedia as an educational tool to improve human papillomavirus vaccine acceptability--a pilot study. Gynecologic oncology. 2010 Academic Article GET IT
Times cited: 20
Role of progesterone in endometrial cancer. Seminars in reproductive medicine. 2010 Review GET IT
Times cited: 153
Synuclein-gamma (SNCG) may be a novel prognostic biomarker in uterine papillary serous carcinoma. Gynecologic oncology. 2009 Academic Article GET IT
Times cited: 27

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

Planning Advance Care Together (PACT) to Improve Engagement in Advance Care Planning among Advanced Cancer Patients awarded by National Cancer Institute Co-Investigator 2022 - 2025

The SISTER Study: Social Interventions for Support during Treatment for Endometrial cancer and Recurrence awarded by National Cancer Institute Principal Investigator Subaward 2021 - 2025

more ...

less ...

Background

education and training

M.D., State University of New York at Stony Brook, School of Medicine 2004
B.S., State University of New York at Stony Brook 1999

Contact

full name

Eloise Chapman

primary email

elc9120@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Eloise Chapman Associate Professor of Obstetrics and Gynecology

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage